Next Article in Journal
Respiratory-Gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers
Previous Article in Journal
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
Open AccessReview

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision

1
Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA
2
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3
The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(2), 57; https://doi.org/10.3390/cancers10020057
Received: 7 December 2017 / Revised: 14 February 2018 / Accepted: 16 February 2018 / Published: 21 February 2018
Current ovarian cancer screening guidelines in high-risk women vary according to different organizations. Risk reducing surgery remains the gold standard for definitive treatment in BRCA mutation carriers, but research advancements have created more short-term options for patients to consider. The decisions involved in how a woman manages her BRCA mutation status can cause a great deal of stress and worry due to the imperfect therapy options. The goal of this review was to critically analyze the screening recommendations and alternative options for high-risk ovarian cancer patients and evaluate how these discrepancies and choices affect a woman’s management decisions. View Full-Text
Keywords: BRCA; ovarian cancer; risk-reducing surgery; CA-125; screening guidelines BRCA; ovarian cancer; risk-reducing surgery; CA-125; screening guidelines
MDPI and ACS Style

Lewis, K.E.; Lu, K.H.; Klimczak, A.M.; Mok, S.C. Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision. Cancers 2018, 10, 57.

AMA Style

Lewis KE, Lu KH, Klimczak AM, Mok SC. Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision. Cancers. 2018; 10(2):57.

Chicago/Turabian Style

Lewis, Kelsey E.; Lu, Karen H.; Klimczak, Amber M.; Mok, Samuel C. 2018. "Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision" Cancers 10, no. 2: 57.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop